Genital ulcer disease: A review
Jaweed Ahmed1, Jyoti Rawre1, Neha Dhawan2
1Department of Microbiology, All India Institute of Medical Sciences, New Delhi, India.
Journal of Family Medicine and Primary Care
|November 10, 2022
Summary
Genital ulcer disease (GUD) is a global health concern and a major HIV risk factor. Herpes simplex virus 2 (HSV-2) is the primary cause, but HSV-1 is emerging, complicating diagnosis and treatment.
Area of Science:
- Infectious Diseases
- Public Health
- Microbiology
Background:
- Genital ulcer disease (GUD) significantly contributes to global morbidity and mortality.
- GUD is a critical risk factor for HIV acquisition.
- Key causative agents include herpes simplex virus 2 (HSV-2), Treponema pallidum, and Haemophilus ducreyi, with HSV-2 being the most prevalent globally.
Purpose of the Study:
- To review the current epidemiology, clinical presentations (typical and atypical), diagnostic challenges, and management strategies for GUD.
- To highlight the evolving role of HSV-1 in GUD and the limitations of traditional diagnostic methods.
- To emphasize the importance of laboratory confirmation and the syndromic approach in resource-limited settings.
Main Methods:
- Literature search of PubMed and Google using terms like "genital ulcer disease," "epidemiology of genital ulcer disease," and "clinical features of genital ulcer disease."
- Selection of relevant literature to provide current perspectives on GUD.
- Review of clinical presentations, diagnostic methods, and management guidelines.
Main Results:
- HSV-2 remains the leading global cause of GUD, but HSV-1 is increasingly implicated.
- Accurate clinical diagnosis is challenging due to atypical presentations and co-infections.
- Molecular methods offer sensitive and rapid microbiological diagnosis, surpassing limitations of standard tests.
Conclusions:
- Effective management of GUD requires accurate diagnosis, considering both typical and atypical presentations.
- Molecular diagnostics are crucial for timely and precise identification of causative pathogens.
- The syndromic management approach remains vital in settings lacking laboratory facilities.
Related Concept Videos
Peptic Ulcer Disease I: Introduction
259
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
259
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
179
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
179
Peptic Ulcer Disease II: Pathophysiology
698
Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
698
Peptic Ulcer Disease IV: Management
128
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
128
Sexually Transmitted Infections
396
Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
396
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
503
Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI) tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
503


